Delving into the chemical profile of Cefoperazone Sodium reveals why it is such an indispensable Active Pharmaceutical Ingredient (API) in modern medicine. As a third-generation cephalosporin antibiotic, its molecular structure and properties are key to its broad-spectrum efficacy, particularly against challenging bacterial strains. NINGBO INNO PHARMCHEM CO.,LTD. is a trusted supplier of pharmaceutical grade Cefoperazone Sodium, ensuring that manufacturers have access to this critical compound with the required purity and quality.

The CAS number 62893-20-3 serves as a unique identifier for Cefoperazone Sodium, facilitating its traceability and management within the pharmaceutical supply chain. The chemical’s ability to combat various bacterial infections, including those caused by Pseudomonas, makes it a valuable asset in therapeutic treatments. For pharmaceutical companies looking to buy Cefoperazone Sodium, understanding its detailed chemical specifications, such as its adherence to USP standards, is essential for developing safe and effective drug products.

NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to maintaining the highest standards in the production and supply of Cefoperazone Sodium. They understand that the integrity of the API directly influences the quality of the final pharmaceutical product. By offering reliable access to this pharmaceutical raw material, they support innovation and production within the healthcare sector. Companies can inquire about the price of Cefoperazone Sodium to integrate this essential chemical into their manufacturing processes.

The importance of APIs like Cefoperazone Sodium cannot be overstated. They form the very foundation of many essential medications. NINGBO INNO PHARMCHEM CO.,LTD. commits to excellence in providing this API, ensuring that pharmaceutical manufacturers can confidently source their needs. Whether for research and development or large-scale production, their focus remains on delivering superior quality Cefoperazone Sodium to meet the evolving demands of the global pharmaceutical market.